Related Experiment Video
Updated: Jun 21, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Clinically important interaction between statin drugs and Clostridium difficile toxin?
Timothy McGuire1, Paul Dobesh, Don Klepser
1College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-6045, United States. trmcguir@unmc.edu
Statins may increase the risk of Clostridium difficile associated disease (CDAD). This study suggests statins potentiate C. difficile toxins, leading to a higher incidence and severity of CDAD.
Area of Science:
- Gastroenterology
- Pharmacology
- Microbiology
Background:
- Clostridium difficile associated disease (CDAD) is increasing in incidence and affecting younger, healthier populations.
- Gastric acid suppression, particularly proton pump inhibitors, is a known risk factor for CDAD.
- C. difficile toxins A and B glucosylates Rho proteins, disrupting cellular pathways.
Purpose of the Study:
- To investigate the potential role of statins as a risk factor for CDAD.
- To explore the mechanism by which statins might potentiate C. difficile toxin effects.
Main Methods:
- Retrospective cohort study comparing CDAD rates in patients receiving statins versus non-statin controls.
- Analysis of the mechanism of Rho protein inhibition by statins and C. difficile toxins.
Main Results:
- Preliminary data from a retrospective cohort showed an increased rate of CDAD in patients taking statins.
- Statins inhibit Rho isoprenylation, a different step than C. difficile toxins, potentially potentiating toxin effects.
Conclusions:
- Statins may interact with C. difficile toxins A and B, increasing the risk and severity of CDAD.
- Further research is warranted to confirm the association between statin use and CDAD.
More Related Videos
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Related Concept Videos
Drug toxicity: Drug–Drug Interaction
Pharmacokinetics: Drug–Drug Interactions
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drug toxicity: Idiosyncratic Reactions